Get started
Author

Daniela Casula

Observed names: Casula, Daniela, D CASULA, D Casula, D. Casula
ORCID: 0000-0001-7111-5946
Observed ORCID: 0000-0001-7111-5946
OpenAlex ID: A5024313625
Safety and Immunogenicity of a Novel Influenza Subunit Vaccine Produced in Mammalian Cell Culture
2009 · Agnieszka Szymczakiewicz‐Multanowska, Nicola Groth, et al. · The Journal of Infectious Diseases · 80
CHF5074 Reduces Biomarkers of Neuroinflammation in Patients with Mild Cognitive Impairment: A 12-Week, Double-Blind, Placebo- Controlled Study
2013 · Joel Ross, Sanjiv Sharma, et al. · Current Alzheimer Research · 78
Non-typeable Haemophilus influenzae protein vaccine in adults with COPD: A phase 2 clinical trial
2019 · Tom M.A. Wilkinson, Stuart Schembri, et al. · Vaccine · 54
PDF
Pharmacokinetics and Pharmacodynamics of CHF5074 After Short-term Administration in Healthy Subjects
2012 · Bruno P. Imbimbo, Enrico Frigerio, et al. · Alzheimer Disease & Associated Disorders · 37
Impact of prior or concomitant seasonal influenza vaccination on MF59-adjuvanted H1N1v vaccine (Focetria™) in adult and elderly subjects
2009 · R. Gasparini, F. Schioppa, et al. · International Journal of Clinical Practice · 37
A randomized clinical trial to identify the optimal antigen and MF59® adjuvant dose of a monovalent A/H1N1 pandemic influenza vaccine in healthy adult and elderly subjects
2012 · Christoph Hatz, Frank von Sonnenburg, et al. · Vaccine · 25
Stepping-across controlled asthmatic patients to extrafine beclometasone/formoterol combination
2013 · Neil Barnes, Jan Arie van Noord, et al. · Pulmonary Pharmacology & Therapeutics · 18
Safety assessment and immunogenicity of a cell-culture-derived influenza vaccine in adults and elderly subjects over three successive influenza seasons
2012 · Agnieszka Szymczakiewicz-Multanowska, Maria Lattanzi, et al. · Human Vaccines & Immunotherapeutics · 15
PDF
Shortening intradermal rabies post-exposure prophylaxis regimens to 1 week: Results from a phase III clinical trial in children, adolescents and adults
2018 · Phirangkul Kerdpanich, Pornthep Chanthavanich, et al. · PLoS neglected tropical diseases · 13
Immunogenicity and safety of a multicomponent meningococcal serogroup B vaccine in healthy adolescents in Korea—A randomised trial
2016 · Hoan Jong Lee, Young June Choe, et al. · Vaccine · 13
Long-term immunogenicity and safety of a non-typeable Haemophilus influenzae-Moraxella catarrhalis vaccine: 4-year follow-up of a phase 1 multicentre trial
2021 · Philippe De Smedt, Geert Leroux-Roels, et al. · Vaccine X · 8
PDF
A randomised phase 2 immunogenicity and safety study of a MF59-adjuvanted quadrivalent subunit inactivated cell-derived influenza vaccine (aQIVc) in adults aged 50 years and older
2025 · Brandon J. Essink, Wim Vermeulen, et al. · Vaccine · 7
A detailed analysis of possible efficacy signals of NTHi-Mcat vaccine against severe COPD exacerbations in a previously reported randomised phase 2b trial
2022 · Ashwani K. Arora, Kenneth Chinsky, et al. · Vaccine · 6
PDF
Immunogenicity, safety, and tolerability of two trivalent subunit inactivated influenza vaccines: a phase III, observer-blind, randomized, controlled multicenter study.
2012 · Miguel W Tregnaghi, Daniel Stamboulian, et al. · PubMed · 6
Immunogenicity and safety of the non-typable Haemophilus influenzae – Moraxella catarrhalis (NTHi-Mcat) vaccine administered following the recombinant zoster vaccine versus administration alone: Results from a randomized, phase 2a, non-inferiority trial
2023 · Ilaria Galgani, Airi Põder, et al. · Human Vaccines & Immunotherapeutics · 5
PDF
Safety and immunogenicity of three doses of non-typeable Haemophilus influenzae-Moraxella catarrhalis (NTHi-Mcat) vaccine when administered according to two different schedules: a phase 2, randomised, observer-blind study
2022 · Ilaria Galgani, Margherita Annaratone, et al. · Respiratory Research · 5
PDF
Immunogenicity and safety of higher-dose cell-based adjuvanted quadrivalent influenza vaccines: Combined results of randomised, controlled dose-finding and dose-confirmation studies
2026 · Fred de Looze, Brandon J. Essink, et al. · Vaccine · 4
Phase III, randomized controlled trial to evaluate lot consistency of a trivalent subunit egg-based influenza vaccine in adults
2012 · Luis Rivera, Sonia Mazara, et al. · Vaccine · 4
[Contribution to the blood enzyme picture during muscular work].
1961 · D CASULA, P CHERCHI, et al. · PubMed · 3
Clinical impact of a non-typeable Haemophilus influenzae (NTHi) adjuvanted vaccine in adults with chronic obstructive pulmonary disease (COPD)
2019 · Daniele Riccucci, Tom Wilkinson, et al. · 2
[Isoflurane pollution in operating rooms].
1988 · C Flore, A Marchi, et al. · PubMed · 2
Adopting the estimand framework in prophylactic vaccine trials
2025 · Francois Beckers, Naveen Karkada, et al. · Vaccine · 1
Corrigendum to ‘A randomised phase 2 immunogenicity and safety study of a MF59-adjuvanted quadrivalent subunit inactivated cell-derived influenza vaccine (aQIVc) in adults aged 50 years and older’ Vaccine 51 (2025) 126791
2025 · Brandon J. Essink, Wim Vermeulen, et al. · Vaccine · 1
Evaluation of an Adaptive Seamless Design for a Phase II/III Clinical Trial in Recurrent Events Data to Demonstrate Reduction in Number of Acute Exacerbations in Patients With Chronic Obstructive Pulmonary Disease (COPD)
2020 · Daniela Casula, Andrea Callegaro, et al. · Statistics in Biopharmaceutical Research · 1
Late Breaking Abstract - Safety and immunogenicity of non-typeable H. influenzae (NTHi) adjuvanted vaccine in older adults with chronic obstructive pulmonary disease (COPD)
2018 · Tom Wilkinson, Stuart Schembri, et al. · 1
Works count: 57
Citation count: 431
H-index: 10
I10-index: 10
Year
Topic
Type